The Search for a Superstar

American Idol News Magazine

Subscribe to American Idol News Magazine: eMailAlertsEmail Alerts newslettersWeekly Newsletters
Get American Idol News Magazine: homepageHomepage mobileMobile rssRSS facebookFacebook twitterTwitter linkedinLinkedIn

American Idol Authors: Gregor Petri, Shelly Palmer

Related Topics: CEOs in Technology, Startup Journal, Venture Capital, Objective-C Developer, American Idol, Google, Entrepreneurs and Innovators

News Feed Item

Cerora, Inc. Wins 2nd Place in Ben Franklin Tech Ventures "Venture Idol" Competition

Surpasses Eight Other Start-Ups Vying for Crowd Funding Grants

BETHLEHEM, PA -- (Marketwired) -- 11/25/13 -- Cerora, ( a member of the StartUp Health and GE Entrepreneurship Program, today announced that they received more than one third the vote, to take second place in Thursday evening's Ben Franklin Tech Ventures prestigious "Venture Idol" competition. Adam Simon, founder of Cerora, presented the company's business plan in a cross between TV's Shark Tank® and American Idol®, including plans for Cerora's real-time bio-sensor-based brain assessment technology, which is intended to rapidly provide objective data on concussions "near the playing field" where they occur.

The day started with a field of 10 start-up companies with the last set of presentations judged by a panel of top venture capital executives, including Glen Bressner (Originate Ventures) and Brett Topche (MentorTech Ventures). Cerora ranked 2nd of the three evening finalists as voted by the audience of 225 start-up ecosystem investors and members. The company will receive its share of the $15,000 prize money.

"It is gratifying to receive such support for Cerora's mission to make a significant positive impact on brain health assessment globally," said Adam Simon, founder and CEO of Cerora. "We've been working hard to build our MindReader™ technology to provide objective measures that can rapidly assist in concussion and traumatic brain injury diagnoses 'near the field,' and this recognition is a significant step toward attracting the funding required to complete the job and fully commercialize our inventions."

Cerora continues to collaborate with Lehigh University Sports Medicine on concussion assessment and return-to-play decisions (topline results anticipated in early 2014). In addition, it will continue to meet biomarker discovery and compound monitoring service contracts in place as it prepares its first software offering for commercial launch in early 2014.

Cerora's Development of Objective Measures of Brain Function
Cerora is developing software and hardware technologies so that brain injury can be evaluated quickly and accurately. The company is investigating how to move from "subjective" brain evaluations to decisions empowered with objective brain biosensor data that can be delivered rapidly as well as delivered right near the location where the patient urgently needs it. These results would mean that certified athletic trainers, medics, nurses, or affiliated healthcare professionals could possibly avoid the subjective judgments that might wrongly put brain-injured athletes "back in the game" or active military personnel "back in harm's way."

About Cerora, Inc.
Based at Ben Franklin Tech Ventures' business accelerator at Lehigh University's Mountaintop Campus in Bethlehem, PA and one of 13 companies selected out of over 400 plus that applied to the GE / StartUp Health Entrepreneur Program, Cerora has assembled a team of experienced healthcare and IT executives to manage the commercialization of its proprietary bio-sensor-based brain evaluation technologies, software, and hardware. To learn more please visit as well as see the recent profile published in Elsevier Business Intelligence's STARTUP magazine at

Media Contact:
Josh Weinstein
Phone: 610-438-8853
Email: [email protected]

Investor Relations Contact:
Russell Miller
Phone: 310-386-2058
Email: [email protected]

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.